Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
72,119,556
-
Total 13F shares
-
19,692,862
-
Share change
-
-4,662,796
-
Total reported value
-
$18,114,763
-
Price per share
-
$0.92
-
Number of holders
-
26
-
Value change
-
-$4,833,042
-
Number of buys
-
10
-
Number of sells
-
9
Institutional Holders of IO Biotech, Inc. - Common (IOBT) as of Q4 2024
As of 31 Dec 2024,
IO Biotech, Inc. - Common (IOBT) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,692,862 shares.
The largest 10 holders included
Vivo Capital, LLC, Novo Holdings A/S, PFM Health Sciences, LP, MARSHALL WACE, LLP, BANK OF AMERICA CORP /DE/, Pivotal bioVenture Partners Investment Advisor LLC, MORGAN STANLEY, Dauntless Investment Group, LLC, LANDSCAPE CAPITAL MANAGEMENT, L.L.C., and CITADEL ADVISORS LLC.
This page lists
26
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.